Thursday, August 29, 2024 12:41:35 PM
I have an L2. Volume is brisk right now. No walls set up on the ASK. 1700 shares is the highest. Most are 100 shares which most likely means the MMs aren't showing all of the shares they are selling at that PPS.
Recent BCDA News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:00:09 PM
- BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:30:15 PM
- BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure • GlobeNewswire Inc. • 04/02/2026 02:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:05:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:31:26 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2026 08:30:33 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/24/2026 08:05:25 PM
- BioCardia Reports 2025 Business Highlights and Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 • GlobeNewswire Inc. • 03/19/2026 11:47:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 10:02:10 AM
- BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA • GlobeNewswire Inc. • 03/17/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 01:01:30 PM
- BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 02:15:23 PM
- BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart • GlobeNewswire Inc. • 02/10/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:47:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 01:00:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/18/2025 10:13:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:00:11 PM
- BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA • GlobeNewswire Inc. • 12/16/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 02:54:52 AM
